Introduction
============

The recent unparalleled discriminatory power afforded by whole-genome sequencing has proven decisive for understanding aspects of bacterial outbreaks, including cholera,^[@bib1],[@bib2]^ tuberculosis,^[@bib3]^ *Listeria monocytogenes*,^[@bib4]^ *Escherichia coli* O104^[@bib5],[@bib6]^ and Group A *Streptococcus* (GAS also known as *streptococcus pyogenes*).^[@bib7],[@bib8],[@bib9]^ Decreasing costs, enhanced data output and improved protocols now make this technology the method of choice for some aspects of public health microbiology.^[@bib10],[@bib11],[@bib12]^ The ease of obtaining genome data permits the study of the evolutionary events contributing to bacterial clone emergence, strain differentiation, and epidemics at the full-chromosomal level in large samples.^[@bib13]^ Toward this end, we have used whole-genome sequencing of GAS as a model to understand the fine-structure and molecular architecture of epidemics occurring over many years.^[@bib7],[@bib8]^

GAS is a human-specific pathogen that causes diseases ranging in severity from uncomplicated pharyngitis to life-threatening necrotizing fasciitis.^[@bib14]^ GAS strains are classified based on the aminoterminal sequence of the M protein, a polymorphic cell-surface adhesin and anti-phagocytic factor encoded by the *emm* gene.^[@bib15],[@bib16],[@bib17]^ Previously, we have used deep-genome sequencing data for 95 *emm3* GAS strains integrated with epidemiological information to resolve the key molecular features of three successive epidemics caused by *emm3* GAS in Ontario, Canada, over a period of 16 years.^[@bib7]^ This comparative pathogenomic analysis delineated the fine-structure molecular population genetics of these epidemics and defined relationships among the invasive strains responsible for the three epidemics.

More recently, using animal infection models and whole-genome sequencing of 601 *emm59* GAS strains, we unambiguously demonstrated that a recently emerged, hypervirulent clone was responsible for a large epidemic of invasive GAS disease that began in 2006 in Western Canada and caused more than 500 invasive cases in 4 years. The epidemic wave extended rapidly to 11 Canadian provinces and territories and to three of the United States.^[@bib8],[@bib18]^ The epidemic clone was distantly related to historic *emm59* GAS strains, and also differed from *emm59* GAS organisms isolated in other countries.^[@bib8],[@bib19]^ Our genomic investigation precisely informed us about the population genomic landscape of the *emm59* GAS epidemic, and permitted us to delineate patterns of geographic dissemination of strains in widely-dispersed areas. We also discovered that, as a population, the *emm59* epidemic isolates have accumulated relatively few genetic polymorphisms over the years since sharing a common ancestor. One hypothesis to explain this finding is that over the course of the four years represented by the *emm59* strain sample used in that previous study, sufficient time has not elapsed to produce considerable genomic differentiation. Extending the genomic analysis by incorporating whole-genome data for epidemic strains more recently isolated will help to differentiate between this and other hypotheses.

Despite the ability to sequence bacterial genomes rapidly, translating the whole-genome data into insightful epidemiological findings remains relatively time consuming and requires intensive logistical and computing resources.^[@bib13]^ In addition, incorporating critical strain or patient metadata into the analysis, and displaying the data in a more visual, intuitive and integrative fashion is challenging. Collectively, these problems hinder the clinical and public health responses to natural and accidental outbreaks, and deliberate release of infectious agents. Thus, methods to rapidly translate genome data into accurate, epidemiologically relevant information in a short period of time are needed. Here, we have attempted to address these limitations by use of whole-genome data from additional strains recovered from the ongoing *emm59* GAS epidemic. Whole-genome data for 90 additional *emm59* GAS strains isolated in Canada were generated and integrated into an improved pipeline for data processing and visualization. We show here that pertinent epidemiological information can be obtained rapidly and economically in meaningful clinical and public health situations.

Materials and methods
=====================

Bacterial strains
-----------------

The strain collection includes 691 *emm59* strains of different origins. 601 of these strains have been described in detail recently.^[@bib8]^ The additional 90 strains ([Table 1](#tbl1){ref-type="table"}) were all isolated in Canada from patients with invasive GAS infections. One of these strains was isolated in 1993 in Ontario, and is thus far the oldest identified Canadian *emm59* GAS organism. Nine strains were isolated during 2006--2009, the period of time covered by our previous report on the *emm59* epidemic,^[@bib8]^ but had not been included in the previous study. The vast majority (*n*=80) of the newly analyzed strains were isolated in 2010 and 2011.

Whole-genome sequencing
-----------------------

DNA was extracted from each of the 90 *emm59* GAS isolates and prepared for multiplexed (barcoded) sequencing as previously described.^[@bib9]^ Genome sequence data were obtained using an Illumina HiSeq2000 instrument according to the manufacturer\'s instructions.

Bioinformatic analysis
----------------------

Bioinformatic analysis was performed using a customized version of the Galaxy Suite^[@bib20],[@bib21],[@bib22]^ running on the Amazon cloud. Namely, we created a pipeline composed of Tagdust,^[@bib23]^ FastQC (<http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/>) and FastX (<http://hannonlab.cshl.edu/fastx_toolkit/>) toolkits, and used it to parse multiplexed sequencing reads, remove barcode information and perform run quality control analyses. Polymorphism discovery was performed using Variant Ascertainment Algorithm.^[@bib24]^ Reads were aligned to the *emm59* GAS strain MGAS15252 (GenBank accession number CP003116) reference genome using the Mosaik assembler (<http://bioinformatics.bc.edu/marthlab/Mosaik>). This strain was isolated in Canada in 2008 and its genome sequenced to closure previously; thus becoming the de facto reference genome for type *emm59* GAS epidemic strains.^[@bib8]^ Unaligned reads were placed into contigs using the Velvet *de novo* assembler.^[@bib25]^ Contigs greater than 100 nucleotides in length were then used to search the NCBI non-redundant database using BLAST.^[@bib26]^

Phylogenetic analysis
---------------------

A matrix file containing the genotype of all strains at each polymorphic locus was created from the Variant Ascertainment Algorithm polymorphism output data using a custom script. Insertions and deletions (indels) were not considered for phylogenetic analysis. Single-nucleotide polymorphisms (SNPs) were concatenated in order of occurrence relative to the reference genome and converted to a multiFASTA sequence. ClustalW^[@bib27]^ was used to align and generate a guide tree for the FASTA sequences. Neighbor-joining phylogenetic trees followed by bootstrap analysis of 1000 replicates were created using SplitsTree^[@bib28]^ and graphically edited with TreeDyn.^[@bib29]^ The Neighbor-joining phylogenetic tree for Canadian epidemic strains isolated 2006--2011 was exported to Path-O-Gen v1.3 (<http://tree.bio.ed.ac.uk/software/pathogen>) and a linear regression plot for isolation date versus root-to-tip distance was generated as described by Mutreja *et al*.^[@bib30]^

Data visualizations
-------------------

Visualizations were created using the resources offered by cBio Inc.\'s Pathogen Annotated Tracking Resource Network located at <http://www.patrn.net/>. Illustrations were created using TIBCO Spotfire and Adobe Illustrator.

Results
=======

Invasive infections caused by *emm59* GAS remain abundant in Canada
-------------------------------------------------------------------

We reported previously that *emm59* GAS strains were almost non-existent in Canada before 2006, but caused more than 500 invasive infections countrywide from that date until early 2010.^[@bib8],[@bib18]^ The epidemic reached its peak in 2008, after which the number of cases began to decline ([Figure 1A](#fig1){ref-type="fig"}). However, *emm59* GAS strains continued to cause invasive infections, with 56 newly identified cases in 2010 (total of 70 cases for 2010), and 32 cases in 2011. Since surveillance for GAS is passive in Canada, the actual number of *emm59* GAS invasive cases is likely to have been higher in the period under investigation. During 2010 and 2011, cases occurred in vastly dispersed geographical areas covering most of the country ([Figure 1B](#fig1){ref-type="fig"}).

The oldest Canadian *emm59* GAS strain identified is not the immediate ancestor of the epidemic *emm59* clone
-------------------------------------------------------------------------------------------------------------

Our previous genome investigation of *emm59* GAS strains recovered in Canada unambiguously demonstrated that regardless of geographic location or year of isolation, epidemic Canadian *emm59* strains have descended from a recent, single ancestral cell that underwent rapid geographic dissemination.^[@bib8]^ The last common ancestor remains unidentified, but it was remarkable that the genomes of the epidemic strains and those of the only seven *emm59* strains isolated in Canada before the epidemic began (1997--2004) were closely related.^[@bib8]^ We sequenced here the genome of an *emm59* strain isolated in Canada in 1993, thus far the oldest Canadian *emm59* organism identified. The genome sequence data show that this strain is genetically distantly related to the epidemic strains and thus is not the recent ancestor. Indeed, compared to reference epidemic strain MGAS15252, the 1993 *emm59* GAS strain had 194 SNPs and 20 indels in the core genome (i.e., the ∼1670 kbp portion of the genome lacking mobile genetic elements that is conserved in gene content across all sequenced *emm* GAS types^[@bib31]^). Phylogenetic analysis using SNP data for the core genomes found that this historic Canadian isolate also is not closely related to non-epidemic *emm59* GAS organisms isolated in other geographic locations such as the United States, Japan or Spain ([Figure 2A](#fig2){ref-type="fig"}).

Comparative genome sequencing of new Canadian epidemic *emm59* strains
----------------------------------------------------------------------

The 89 additional *emm59* GAS Canadian organisms differed from the reference strain, on average, by 10 SNPs and 3.4 indels (median 12 SNPs, 3 indels). The notable exception was strain MGAS24525, isolated in Manitoba in 2010, which had 465 SNPs and 71 indels relative to the reference strain. However, the vast majority of these polymorphisms mapped to mobile genetic elements, namely, prophages present in the reference sequence. Indeed, compared with the core genome of the reference strain, the number of polymorphisms was reduced to only 30 SNPs and 5 indels. Moreover, 15 of these 30 SNPs mapped to sequences in close vicinity of prophage boundaries. These results suggest that strain MGAS24525 is a *bona fide emm59* GAS epidemic strain that has very recently acquired a different prophage. Phylogenetic analysis using the whole-genome data showed that the Canadian *emm59* GAS organisms clustered tightly in the epidemic complex ([Figure 2A](#fig2){ref-type="fig"}).

Epidemic Canadian *emm59* GAS strains continue to undergo clonal expansion
--------------------------------------------------------------------------

One of the findings of our previous work was that, as a population, the *emm59* epidemic isolates have accumulated relatively few genetic polymorphisms over the years since sharing a last common ancestor. One hypothesis to explain that finding is that over the course of the 4 years represented by the *emm59* strains used in the previous study, sufficient time has not elapsed to produce considerable genomic differentiation. Adding to the analysis data for 80 additional strains isolated in 2010--2011 provided us with the ability to test the hypothesis over a period of time of almost 6 years. Phylogenetic analysis of strains isolated during 2010--2011 found that these recent strains were located, in general, toward the tip of multiple branches of the phylogenetic tree, implying that they have accumulated additional SNPs compared to *emm59* GAS organisms isolated previously ([Figure 2B](#fig2){ref-type="fig"}). When we divided the strain collection based on isolation year and calculated the average number of SNPs separating the epidemic strains isolated in a given year from the reference strain, we noticed an increase in the number of polymorphisms differentiating the epidemic strains from the reference strain over time. For example, epidemic strains recovered in 2006 differed from the reference genome, on average, by 7.6 SNPs, whereas strains isolated in 2011 differed, on average, by 13.1 SNPs. To test the hypothesis in more detail, we performed a linear regression analysis on all epidemic strains isolated since 2006 to calculate the rate of SNP accumulation on the basis of the date of isolation and the root-to-tip distance. Consistent with the hypothesis, linear regression analysis showed a steady rate of SNP accumulation (*R*^2^=0.6067; [Figure 3](#fig3){ref-type="fig"}) in the core genome.

Use of whole-genome data to study temporospatial spread of *emm59* GAS subclones
--------------------------------------------------------------------------------

Among the critical questions that whole-genome sequencing and subsequent phylogenetic analyses can address is whether an apparent epidemic represents the emergence of a single distinct genotype, or, instead, it is caused by multiple clones that emerged simultaneously. In our initial investigation, we unambiguously demonstrated the *emm59* GAS epidemic was caused by the emergence of a distinct genetic clone.^[@bib8]^ The extensive whole-genome data also permitted us to delineate clear patterns of geographic dissemination of derivative subclones.^[@bib8]^ We inferred that these geographic patterns were the result of the rapid spread of subclones in distinct geographic regions of the country. We hypothesized that the geographical patterns will begin to be obscured over time as a result of geographic mixing of subclones linked to human travel. [Figure 4A](#fig4){ref-type="fig"} clearly exemplifies how whole-genome data support this hypothesis: a subclone that before 2009 was composed only of strains isolated in the provinces of Alberta and British Columbia has expanded to four other Canadian provinces and territories. Mixing of the subclones is also clearly revealed among strains isolated in Quebec. Type *emm59* GAS had been isolated in Quebec in 1996 and 2004, particularly in northern areas of the province. Quebec interrupted the provincial GAS surveillance program during 2005--2009. We discovered that none of the 28 *emm59* GAS invasive cases reported in the province since 2009 was caused by direct lineal descendants of the strains originally identified in Quebec. Rather, they were caused by strains of genetically divergent *emm59* subclones isolated first in other parts of Canada and subsequently introduced into the province on at least four different occasions ([Figure 4B and 4C](#fig4){ref-type="fig"}). Notably, we identified five strains whose genomes were essentially identical. Four of these strains were isolated from patients receiving care in the Montreal area, whereas the fifth was from a patient in Ontario. This is incontrovertible evidence that the strains have shared a very recent common ancestor and, also, most likely represents that the patients infected by these strains were connected to one another, either directly or via an unknown third-party donor. Temporal analysis revealed that the Ontario case was the last to be isolated ([Figure 4D](#fig4){ref-type="fig"}), indicating a reversal of the west to east route of transmission identified in our previous study.^[@bib8]^

Convergent evolution of polymorphisms in virulence genes
--------------------------------------------------------

The radial structure of the epidemic phylogenetic tree ([Figure 2B](#fig2){ref-type="fig"}) suggested that most of the SNPs identified in our strain collection arose once and were transmitted vertically by descent. Polymorphisms that arise independently multiple times are of interest since they may represent genetic changes that are under evolutionary selection because they confer an advantage to the organism. We identified several examples of these polymorphisms, including a single nucleotide deletion in a homopolymeric tract of 7 Ts, predicted to result in premature termination of translation of CovS, the sensor kinase of the two-component regulatory system CovRS. This component regulatory system influences the expression of a large regulon that includes many virulence genes.^[@bib32]^ CovR acts primarily as a transcriptional repressor of virulence genes. Inactivation of *covR* or *covS* has been reported to increase GAS virulence in strains of several different *emm* types.^[@bib32]^ The distribution of this deletion-mutation strongly suggests that it evolved independently on least six different occasions in *emm59* GAS strains ([Figure 5](#fig5){ref-type="fig"}). We also identified multiple different non-synonymous SNPs in the *mga* gene which encodes a stand alone global regulator of GAS virulence. Mga is important at several steps of the pathogenesis of the GAS infection, and is required for full GAS virulence in a skin model of infection.^[@bib33],[@bib34]^ The phylogenetic distribution of one of these SNPs (resulting in a His201Arg amino-acid replacement) strongly suggests that it arose independently at least six times ([Figure 5](#fig5){ref-type="fig"}).

Discussion
==========

Our study supports the idea that performing whole-genome sequencing and data interpretation rapidly can have a major impact on the study and management of epidemics. New and improved sequencing systems permit genome sequence data to be generated economically for hundreds of strains in as little as a week. A time frame as short as 1.5 days has been reported for obtaining high-quality genome data for a small number of strains.^[@bib35]^ However, data analysis continues to be a key bottleneck in genome sequence-based investigations.

During an epidemic, irrespective of whether it is natural or caused by the accidental or deliberate release of a pathogenic organism, there is substantial pressure to obtain high-quality genome and linked epidemiologic information very rapidly. It is therefore important to identify exactly what is being traced at as high resolution as possible. Important questions to be addressed are: Is this a clonal outbreak or are several pathogen genetic backgrounds involved? What is the nature and extent of organism evolution during the course of the epidemic? Here, using an improved data analysis pipeline, we have been able to accurately identify polymorphisms for 90 strains in less than 24 h after obtaining the raw data from the sequencing instrument. As importantly, we were able to integrate new and preexisting data along with geographical and temporal strain metadata to rapidly generate phylogenetic trees and other visualizations that translated the data into intuitive and insightful epidemiological information. By applying this analysis, we were able to differentiate among *emm59* GAS subclones causing disease in different and geographically dispersed parts of Canada, and obtain new information about how these clones are expanding and mixing over time.

Two other important issues when studying an epidemic are identifying the origin of the organism(s) causing it and the ability to exclude or confirm genetic modifications. By limiting our analysis to the province of Quebec, we demonstrated that whole-genome sequencing, phylogenetic and temporospatial analysis were able to assign the different cases reported in the province to at least five different subclones of *emm59* GAS. Moreover, we unambiguously demonstrated transmission of a particular subclone which has been active for months in the Montreal area to the province of Ontario. This type of crucial information is important for providing input on public health maneuvers, for understanding strain spreading and for inferring whether an epidemic is naturally caused or potentially the result of deliberate release of a pathogenic organism.

Whole-genome sequencing of large numbers of strains causing epidemics has also proven useful to characterize many biological properties of the organisms under investigation and is revolutionizing both virulence factor discovery and characterization and our understanding of bacterial pathogenesis.^[@bib36],[@bib37],[@bib38]^ In our analysis of the *emm59* GAS epidemic in Canada, we rapidly identified several polymorphisms that arose multiple, independent times in the strains studied. Among others, we discovered such polymorphisms in global regulators of GAS virulence, such as a nucleotide deletion in the *covS* gene and a SNP resulting in a non-synonymous amino-acid change at position 201 of the predicted translated sequence of the standalone regulator Mga. Selection within the host of these polymorphisms may denote that they are of importance for the pathogenesis of infection. Although evaluating the potential involvement of these naturally occurring polymorphisms in GAS virulence requires further time and effort, it is worth noting that whole-genome sequencing analysis can lead to the quick generation of research hypothesis bearing on pathogenesis even during the initial analysis of epidemics.

In this study, we limited our analysis to genome data and temporospatial isolation information for bacterial strains. It would be possible, however, to rapidly build a well-curated database integrating other metadata such as, for example, disease manifestation and patient information, including patient genome data. Such efforts are currently underway in some clinical settings.^[@bib13]^ Whole-genome sequencing and integrative metadata analysis holds the promise of monitoring the spread and evolution of pathogens in real time, facilitating management of disease and patient treatment and continuing to provide leads for future research aimed at deciphering the virulence arsenal of pathogenic bacteria. The strategy we used here is a step forward in the route toward automation of whole-genome sequencing data analysis and provides a framework upon which to build more intuitive, rapid and precise analytic tools.
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![Number of *emm59* GAS recorded cases in Canada and their geographic distribution since the beginning of the epidemic. (**A**) The epidemic began in year 2006 and reached its peak in 2008. By that year, cases of invasive disease were recorded over the vast majority of the country. The number of cases started to decline since 2009. However, in years 2010 and 2011, strains could still be recovered in relatively large numbers. (**B**) Temporospatial display of strain origin. Provinces in which *emm59* GAS strains were isolated are color coded based on the number of strain isolated each year. Numbers indicate the exact number of strains isolated in a particular year in each province.](emi201313f1){#fig1}

![(**A**) Inferred genetic relationships among strains based on 1443 concatenated SNP loci identified by whole-genome sequencing. Newly sequenced strains all cluster within the epidemic clonal complex, with the exception of a Canadian *emm59* GAS strain isolated in 1993. This strain is also genetically distant from invasive strains from Spain, Japan and the United States. Scale bar represents genetic distance. (**B**) Magnification of the epidemic complex part of the tree, showing the geographical area of isolation (Canadian province or US state). Strains recovered during years 2010--2011 are highlighted. In general, these more recent strains are found in the outermost part of every tree branch.](emi201313f2){#fig2}

![Linear regression plot showing the correlation (*R*^2^) between the root-to-tip distance (*y*-axis) and the date of the epidemic strains (*x*-axis).](emi201313f3){#fig3}

![(**A**) Geographic patterns of strains dissemination are diluted as the epidemic progresses over time. The highlighted areas of the tree exemplifies how specific subclones, previously restricted to specific geographical areas of Canada before 2009, are now found over vast regions of the country. Triangles represent *emm59* GAS strains not considered for the analysis. (**B**) Epidemic strains isolated in the province of Quebec since 2009 were introduced into the province in at least five different occasions. Strains from Quebec are depicted in blue and their different locations in the phylogenetic tree highlighted by the black ellipses. With the exception of a 'native\' population of strains isolated before 2006, all cases in the province were the result of the introduction of multiple different *emm59* GAS subclones active in other parts of Canada. (**C**) Introduction of the different genotypes into Quebec can be precisely mapped back to the origin strain. (**D**) Magnification of a region of the phylogenetic depicting a subclone composed of five strains of identical genome sequence which caused disease in the Montreal area, but was later isolated in the province of Ontario.](emi201313f4){#fig4}

![Different polymorphisms arose multiple, independent times. Polymorphism analysis identified that several strains in different branches of the phylogenetic tree present either a nucleotide deletion (del T83) resulting in premature termination of the translation of the global regulator *covS* (indicated in red) and/or a SNP (A601C) resulting in a nonsynonymous amino acid replacement (His201Arg) in the stand alone regulator Mga (indicated in light blue). These polymorphisms could not have been inherited by descent. Their multiple, independent acquisition within the host suggests that they confer a selective advantage.](emi201313f5){#fig5}

###### Type *emm59* GAS strains incorporated in this study

  ID    Strain name   Isolation date         Province                   Source
  ---- ------------- ---------------- ----------------------- ---------------------------
  1      MGAS23789        Oct-10              Alberta                 Neck tissue
  2      MGAS23790        Jan-10              Alberta                    Blood
  3      MGAS23791        Jul-11              Alberta             Bursa Lt olecranon
  4      MGAS23792        Mar-11              Alberta                 Knee fluid
  5      MGAS23793        Jul-10              Alberta               Synovial elbow
  6      MGAS23794        Feb-10              Alberta                    Blood
  7      MGAS23795        Apr-11              Alberta                    Blood
  8      MGAS23796        Mar-11              Alberta                    Blood
  9      MGAS23798        Mar-10              Alberta                    Blood
  10     MGAS23800        Aug-10              Alberta                    Blood
  11     MGAS23801        Apr-10              Alberta                 Knee fluid
  12     MGAS23802        Apr-10              Alberta                    Blood
  13     MGAS23803        Dec-10              Alberta                    Blood
  14     MGAS23805        Apr-10              Alberta                    Blood
  15     MGAS23806        Jul-10              Alberta                   Leg Rt
  16     MGAS23808        Nov-10              Alberta                    Blood
  17     MGAS23809        Mar-11              Alberta                    Blood
  18     MGAS23810        Mar-11              Alberta                    Blood
  19     MGAS23811        Nov-10              Alberta              Blood peripheral
  20     MGAS23812        May-11              Alberta                    Blood
  21     MGAS23813        Feb-10              Alberta             Abscess chest wall
  22     MGAS23814        Feb-11              Alberta                    Blood
  23     MGAS23815        Nov-10              Alberta                    Blood
  24     MGAS23816        Nov-10              Alberta            Tissue axilla abscess
  25     MGAS23817        Jun-10              Alberta                Abscess neck
  26     MGAS23818        Nov-10              Alberta                    Blood
  27     MGAS23819        Nov-10              Alberta                    Blood
  28     MGAS23787        Jan-10         British Columbia           Synovial fluid
  29     MGAS23797        Dec-09         British Columbia                Blood
  30     MGAS23799        Mar-10         British Columbia             Peritoneal
  31     MGAS24513        Jun-10         British Columbia                Blood
  32     MGAS24520        Oct-10         British Columbia      Undetermined sterile site
  33     MGAS24522        Nov-10         British Columbia                Blood
  34     MGAS24527        Dec-10         British Columbia      Undetermined sterile site
  35     MGAS24530        Feb-11         British Columbia                Blood
  36     MGAS24533        Jun-11         British Columbia                Blood
  37     MGAS24535        Jul-11         British Columbia           Synovial fluid
  38     MGAS24537        Aug-11         British Columbia                Blood
  39     MGAS24541        Aug-11         British Columbia           Synovial fluid
  40     MGAS24542        Aug-11         British Columbia                Blood
  41     MGAS24509        Apr-10             Manitoba          Undetermined sterile site
  42     MGAS24512        Jun-10             Manitoba                  Not given
  43     MGAS24525        Dec-10             Manitoba          Undetermined sterile site
  44     MGAS24538        Aug-11             Manitoba                   Abscess
  45     MGAS24540        Aug-11             Manitoba               Synovial fluid
  46     MGAS25517        Sep-10             Manitoba                    Blood
  47     MGAS24516        Aug-10       Northwest Territories             Blood
  48     MGAS24510        May-10              Nunavut                    Blood
  49     MGAS23788        Jan-10              Ontario                    Blood
  50     MGAS23804        Feb-10              Ontario                Fluid Rt knee
  51     MGAS24220        Dec-93              Ontario          Undetermined sterile site
  52     MGAS24223        Mar-06              Ontario          Undetermined sterile site
  53     MGAS24224        Jun-06              Ontario          Undetermined sterile site
  54     MGAS24225        Dec-06              Ontario          Undetermined sterile site
  55     MGAS24226        May-08              Ontario          Undetermined sterile site
  56     MGAS24227        Oct-08              Ontario          Undetermined sterile site
  57     MGAS24229        Mar-09              Ontario          Undetermined sterile site
  58     MGAS24230        Dec-09              Ontario          Undetermined sterile site
  59     MGAS24232        Feb-10              Ontario          Undetermined sterile site
  60     MGAS24233        Jul-10              Ontario          Undetermined sterile site
  61     MGAS24234        Aug-10              Ontario          Undetermined sterile site
  62     MGAS24235        Jul-10              Ontario          Undetermined sterile site
  63     MGAS24236        Nov-10              Ontario          Undetermined sterile site
  64     MGAS24237        May-11              Ontario          Undetermined sterile site
  65     MGAS24511        May-10              Ontario                  Not given
  66     MGAS24514        Jul-10              Ontario                    Blood
  67     MGAS24529        Feb-11              Ontario                    Blood
  68     MGAS24544        Sep-11              Ontario                    Blood
  69     MGAS24545        Sep-11              Ontario                    Blood
  70     MGAS24547        Oct-11              Ontario               Synovial fluid
  71     MGAS23524        Nov-10              Quebec                Synovial fluid
  72     MGAS23786        Jan-10              Quebec                     Blood
  73     MGAS23807        Dec-09              Quebec                     Blood
  74     MGAS24507        Mar-10              Quebec                     Blood
  75     MGAS24508        Feb-10              Quebec                     Blood
  76     MGAS24518        Oct-10              Quebec                     Blood
  77     MGAS24523        Nov-10              Quebec                     Blood
  78     MGAS24526        Dec-10              Quebec                     Blood
  79     MGAS24528        Dec-10              Quebec                     Blood
  80     MGAS24531        Mar-11              Quebec                     Blood
  81     MGAS24532        Mar-11              Quebec                Synovial fluid
  82     MGAS24534        Jun-11              Quebec           Undetermined sterile site
  83     MGAS24536        Aug-11              Quebec                     Blood
  84     MGAS24543        Aug-11              Quebec                Synovial fluid
  85     MGAS24546        Oct-11              Quebec                     Blood
  86     MGAS24548        Oct-11              Quebec                     Blood
  87     MGAS24505        Jan-10           Saskatchewan                  Blood
  88     MGAS24506        Mar-10           Saskatchewan                  Blood
  89     MGAS24515        Aug-10           Saskatchewan                  Blood
  90     MGAS24519        Oct-10           Saskatchewan                  Blood

Abbreviations: Lt, left; Rt, right.

[^1]: Present address: Public Health Ontario, Toronto, Ontario M9P 3T1, Canada
